MEDIANA Co.Ltd (041920) - Cash Flow Conversion Efficiency
Based on the latest financial reports, MEDIANA Co.Ltd (041920) has a cash flow conversion efficiency ratio of -0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.17 Billion ≈ $-1.47 Million USD) by net assets (₩132.36 Billion ≈ $89.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 041920 stock market capitalisation for the company's overall valuation and market capitalisation.
MEDIANA Co.Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how MEDIANA Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
MEDIANA Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MEDIANA Co.Ltd ranked by their cash flow conversion efficiency. Explore MEDIANA Co.Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
IBKS No2 SPAC
KQ:204840
|
-0.088x |
|
Sam Jung Pulp
KO:009770
|
0.001x |
|
Lion Chemtech Co. Ltd
KQ:171120
|
0.012x |
|
Tevogen Bio Holdings Inc.
NASDAQ:TVGN
|
0.338x |
|
Sequana Medical NV
BR:SEQUA
|
0.254x |
|
Hardwyn India Limited
NSE:HARDWYN
|
0.012x |
|
Ozerden Plastik Sanayi
IS:OZRDN
|
0.718x |
|
Kalina Power Ltd
AU:KPO
|
1.221x |
Annual Cash Flow Conversion Efficiency for MEDIANA Co.Ltd (2014–2024)
The table below shows the annual cash flow conversion efficiency of MEDIANA Co.Ltd from 2014 to 2024. View current stock price of MEDIANA Co.Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩127.80 Billion ≈ $86.61 Million |
₩5.11 Billion ≈ $3.46 Million |
0.040x | -72.40% |
| 2023-12-31 | ₩100.64 Billion ≈ $68.20 Million |
₩14.57 Billion ≈ $9.87 Million |
0.145x | +34.39% |
| 2022-12-31 | ₩90.06 Billion ≈ $61.03 Million |
₩9.70 Billion ≈ $6.57 Million |
0.108x | -30.11% |
| 2021-12-31 | ₩78.74 Billion ≈ $53.36 Million |
₩12.13 Billion ≈ $8.22 Million |
0.154x | +11.89% |
| 2020-12-31 | ₩68.31 Billion ≈ $46.29 Million |
₩9.41 Billion ≈ $6.38 Million |
0.138x | -35.63% |
| 2019-12-31 | ₩56.94 Billion ≈ $38.59 Million |
₩12.18 Billion ≈ $8.26 Million |
0.214x | +185.06% |
| 2018-12-31 | ₩49.44 Billion ≈ $33.51 Million |
₩3.71 Billion ≈ $2.51 Million |
0.075x | +224.52% |
| 2017-12-31 | ₩43.82 Billion ≈ $29.70 Million |
₩1.01 Billion ≈ $686.80K |
0.023x | -87.94% |
| 2016-12-31 | ₩42.75 Billion ≈ $28.97 Million |
₩8.20 Billion ≈ $5.56 Million |
0.192x | -12.75% |
| 2015-12-31 | ₩34.91 Billion ≈ $23.66 Million |
₩7.67 Billion ≈ $5.20 Million |
0.220x | +722.97% |
| 2014-12-31 | ₩27.30 Billion ≈ $18.50 Million |
₩728.97 Million ≈ $494.01K |
0.027x | -- |
About MEDIANA Co.Ltd
Mediana Co.,Ltd, together with its subsidiaries, develops, manufactures, and sells medical devices in South Korea. It offers patient monitors, vital signs monitors, AEDs, monitors/defibrillators, fetal products, body composition analyzers, central monitoring systems, face masks, spot checks and monitors, pulse oximeters, and physio modules. The company also exports ODM and own branded products th… Read more